128 results
-
List item
Human medicine European public assessment report (EPAR): Viread
tenofovir disoproxil fumarate, Hepatitis B, Chronic; HIV Infections
Date of authorisation: 04/02/2002, Revision: 58, Authorised, Last updated: 04/01/2023 -
List item
Human medicine European public assessment report (EPAR): Dzuveo
sufentanil citrate, Pain
Date of authorisation: 25/06/2018, Revision: 6, Authorised, Last updated: 31/03/2023 -
List item
Human medicine European public assessment report (EPAR): Cosentyx
Secukinumab, Arthritis, Psoriatic; Psoriasis; Spondylitis, Ankylosing
Date of authorisation: 14/01/2015, Revision: 34, Authorised, Last updated: 30/08/2023 -
List item
Human medicine European public assessment report (EPAR): Opzelura
ruxolitinib phosphate, Vitiligo
Date of authorisation: 19/04/2023, Revision: 1, Authorised, Last updated: 22/06/2023 -
List item
Human medicine European public assessment report (EPAR): Xofigo
radium (223Ra) dichloride, Prostatic Neoplasms
Date of authorisation: 13/11/2013,
, Revision: 13, Authorised, Last updated: 16/05/2023
-
List item
Human medicine European public assessment report (EPAR): Sialanar
Glycopyrronium bromide, Sialorrhea
Date of authorisation: 15/09/2016, Revision: 10, Authorised, Last updated: 19/06/2023 -
List item
Human medicine European public assessment report (EPAR): Jakavi
ruxolitinib (as phosphate), Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease
Date of authorisation: 23/08/2012, Revision: 28, Authorised, Last updated: 31/07/2023 -
List item
Human medicine European public assessment report (EPAR): Doptelet
avatrombopag maleate, Thrombocytopenia
Date of authorisation: 20/06/2019,, Revision: 5, Authorised, Last updated: 20/06/2021
-
List item
Human medicine European public assessment report (EPAR): Xeloda
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 02/02/2001, Revision: 30, Authorised, Last updated: 26/10/2022 -
List item
Human medicine European public assessment report (EPAR): Capecitabine Teva
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012,
, Revision: 15, Authorised, Last updated: 08/09/2021
-
List item
Human medicine European public assessment report (EPAR): Stocrin
efavirenz, HIV Infections
Date of authorisation: 28/05/1999, Revision: 49, Authorised, Last updated: 25/04/2023 -
List item
Human medicine European public assessment report (EPAR): Sustiva
efavirenz, HIV Infections
Date of authorisation: 28/05/1999, Revision: 48, Authorised, Last updated: 25/05/2023 -
List item
Human medicine European public assessment report (EPAR): Inrebic
fedratinib dihydrochloride monohydrate, Myeloproliferative Disorders; Primary Myelofibrosis
Date of authorisation: 08/02/2021,, 
, Revision: 4, Authorised, Last updated: 21/03/2023
-
List item
Human medicine European public assessment report (EPAR): Viramune
nevirapine, HIV Infections
Date of authorisation: 04/02/1998, Revision: 44, Authorised, Last updated: 21/04/2023 -
List item
Human medicine European public assessment report (EPAR): Combivir
lamivudine, zidovudine, HIV Infections
Date of authorisation: 18/03/1998, Revision: 37, Authorised, Last updated: 29/08/2022 -
List item
Human medicine European public assessment report (EPAR): Staquis
Crisaborole, Dermatitis, Atopic
Date of authorisation: 27/03/2020,, Revision: 6, Withdrawn, Last updated: 08/02/2022
-
List item
Human medicine European public assessment report (EPAR): Enzepi
pancreas powder, Exocrine Pancreatic Insufficiency
Date of authorisation: 29/06/2016,, Revision: 1, Withdrawn, Last updated: 17/02/2021
-
List item
Human medicine European public assessment report (EPAR): Capecitabine SUN
capecitabine, Stomach Neoplasms; Breast Neoplasms; Colonic Neoplasms; Colorectal Neoplasms
Date of authorisation: 21/06/2013,, Revision: 3, Withdrawn, Last updated: 22/12/2016
-
List item
Human medicine European public assessment report (EPAR): Triumeq
dolutegravir sodium, lamivudine, abacavir (as sulfate), HIV Infections
Date of authorisation: 31/08/2014, Revision: 31, Authorised, Last updated: 20/04/2023 -
List item
Human medicine European public assessment report (EPAR): Stribild
elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 24/05/2013, Revision: 25, Authorised, Last updated: 02/02/2023 -
List item
Human medicine European public assessment report (EPAR): Epivir
lamivudine, HIV Infections
Date of authorisation: 08/08/1996, Revision: 50, Authorised, Last updated: 29/08/2022 -
List item
Human medicine European public assessment report (EPAR): Remicade
infliximab, Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Crohn Disease; Arthritis, Psoriatic; Colitis, Ulcerative
Date of authorisation: 13/08/1999, Revision: 61, Authorised, Last updated: 26/09/2022 -
List item
Human medicine European public assessment report (EPAR): Avandia
rosiglitazone, Diabetes Mellitus, Type 2
Date of authorisation: 11/07/2000, Revision: 23, Withdrawn, Last updated: 08/06/2016 -
List item
Veterinary medicine European public assessment report (EPAR): Masivet
Masitinib mesilate, Dogs
Date of authorisation: 17/11/2008, Revision: 6, Authorised, Last updated: 26/09/2013 -
List item
Human medicine European public assessment report (EPAR): Viracept
nelfinavir, HIV Infections
Date of authorisation: 22/01/1998, Revision: 25, Withdrawn, Last updated: 10/06/2014